SCHEMBL24065765

SCHEMBL24065765

N#Cc1cc(C#N)cc(-c2ccc(-c3ccc(-c4nc(-c5cccc6ccccc56)c5ccccc5n4)c4ccccc34)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.44
CYP1A2 P05177 8/20 0.41
CYP3A4 P08684 6/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
ALDH1A1 P00352 5/20 0.41
CYP2C19 P33261 4/20 0.41
LMNA P02545 4/20 0.41
CYP2D6 P10635 4/20 0.41
CLK4 Q9HAZ1 3/20 0.41
HSD17B10 Q99714 3/20 0.41
CYP2C9 P11712 3/20 0.41
TSHR P16473 3/20 0.41
MAPK1 P28482 2/20 0.41
TP53 P04637 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 2/20 0.39
ALOX15 P16050 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065803 1.00 ADORA2A (0.44) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065767 0.95 ADORA2A (0.46) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065804 0.95 CYP1A2 (0.46) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065795 0.92 ABCG2 (0.43) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065828 0.92 ABCG2 (0.43) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065763 0.88 MEN1 (0.50) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065802 0.88 CYP1A2 (0.50) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065818 0.88 CYP1A2 (0.50) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065770 0.88 MEN1 (0.50) ADORA2ACYP1A2CYP3A4MEN1KMT2A
SCHEMBL24065725 0.87 ADORA2A (0.43) ADORA2ACYP1A2CYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC4, CRY1, TRPC1 ADORA2A 3738/4885CYP1A2 181/4885CYP3A4 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.